Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis [NA]
This clinical trial update describes evaluating a formalized care support program after an acute leukemia diagnosis; the study is not yet re…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia [NA]
This ClinicalTrials.gov entry describes the Emotion and Symptom-Focused Engagement Trial for individuals with acute leukemia, sponsored by t…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Clonal Hematopoiesis of Immunological Significance
This is a clinical trial update about clonal hematopoiesis of immunological significance (CHIS) sponsored by Assistance Publique - Hôpitaux …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial update describes a new double epigenetic regimen being studied in relapsed or refractory acute myeloid leukemia, with the st…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: BY002 IIT Study in R/R Acute Leukemia [Phase 1]
Investigator-initiated phase 1 trial of BY002 in relapsed/refractory acute leukemia, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
This clinical trial update outlines a natural history study to characterize drug metabolism phenotype in patients undergoing allogeneic hema…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating nivolumab and/or ipilimumab with or without azacitidine for myelodysplastic syndromes; currently active but not rec…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant [Phase 1]
A Phase 1 clinical trial evaluating Revumenib for acute leukemia in patients after allogeneic stem cell transplant; the study is currently r…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia [NA]
This clinical trial update describes a study evaluating a spiritual care intervention for adults diagnosed with acute leukemia. The trial is…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) [NA]
A hematology-focused clinical trial update for HEM-Profiling 2021, currently recruiting to explore chemogenomic profiling across multiple le…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Feasibility of a Multi-omics Platform for Hematological Malignancies [NA]
This clinical trial update assesses the feasibility of a multi-omics platform for hematological malignancies and is currently recruiting. It…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC [EARLY_Phase 1]
An early-phase expanded-access protocol evaluating CD3+/CD19+ depleted peripheral blood stem cells for leukemia and related immunodeficiency…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care [NA]
This clinical trial update describes a University of Miami-sponsored study evaluating how Leukemia & Lymphoma Society services affect patien…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes [Phase 2]
This is a Phase II clinical trial evaluating the menin inhibitor revumenib in patients with leukemia associated with upregulation of HOX gen…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma [Phase 1, Phase 2]
This is a pediatric and young adult Phase 1/2 clinical trial evaluating a CD22-directed CAR-T cell therapy for relapsed or refractory leukem…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) [NA]
A clinical trial update describing the Italian Tumor Chemogenomic Profiler (IT-TCP), an integrative multi-omics and functional platform to d…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Pathogenesis of Hematologic Malignancies
An update on an ongoing clinical trial exploring the pathogenesis of hematologic malignancies, with enrollment by invitation at the sponsor …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
The study investigates cachexia frequency in ambulatory cancer patients and the psychological burden on patients and their primary caregiver…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Weight Gain in Pediatric Leukemia Survivors [NA]
A clinical trial examining weight gain in pediatric leukemia survivors, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study evaluating roginolisib (IOA-244) in combination with venetoclax and rituximab for patie…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer [Phase 2]
Phase 2 clinical trial comparing GEO-CM04S1 vaccine to an mRNA SARS-CoV-2 vaccine in patients with hematologic malignancies; the study is cu…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Cancer Stem Cells in Acute Leukemia
Sanford Health is conducting an active, not recruiting clinical trial on cancer stem cells in patients with acute leukemia.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies [Phase 1]
Phase 1 trial evaluating autologous CD22-directed CAR T cells after prior commercial CD19-directed CAR T therapy in patients with B-cell mal…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax [Phase 1, Phase 2]
A multi-site Phase 1/2 trial evaluating a three-drug regimen (tagraxofusp, azacitidine, and venetoclax) for measurable residual disease in a…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors [NA]
Clinical trial update describing a mindfulness intervention study for childhood cancer survivors aimed at improving health activation, copin…